Apolipoprotein E (apoE) is an important lipid-transport protein in human pl
asma and brain. It has three common isoforms (apoE2, apoE3, and apoE4), Apo
E is a major genetic risk factor in heart disease and in neurodegenerative
disease, including Alzheimer's disease. The interaction of apoE with hepara
n sulfate proteoglycans plays an important role in lipoprotein remnant upta
ke and likely in atherogenesis and Alzheimer's disease, Here we report our
studies of the interaction of the N-terminal domain of apoE4 (residues 1-19
1), which contains the major heparin-binding site, with an enzymatically pr
epared heparin oligosaccharide. Identified by its high affinity for the N-t
erminal domain of apoE4, this oligosaccharide was determined to be an octas
accharide of the structure Delta UAp2S(1-->[4)-alpha -D-GlcNpS6S(1-->4)-alp
ha -L-IdoAp2S(1-->](3)4)-alpha -D-GlcNpS6S by nuclear magnetic resonance sp
ectroscopy, capillary electrophoresis, and polyacrylamide gel electrophores
is. Kinetic analysis of the interaction between the N-terminal apoE4 fragme
nt and immobilized heparin by surface plasmon resonance yielded a K-d of 15
0 nM. A similar binding constant (K-d = 140 nM) was observed for the intera
ction between immobilized N-terminal apoE4 and the octasaccharide. Isotherm
al titration calorimetry revealed a K-d of 75 nM for the interaction of the
N-terminal apoE fragment and the octasaccharide with a binding stoichiomet
ry of approximately 1:1. Using previous studies and molecular modeling, we
propose a binding site for this octasaccharide in a basic residue-rich regi
on of helix 4 of the N-terminal fragment. From the X-ray crystal structure
of the N-terminal apoE4, we predicted that binding of the octasaccharide at
this site would result in a change in intrinsic fluorescence. This predict
ion was confirmed experimentally by an observed increase in fluorescence in
tensity with octasaccharide binding corresponding to a K-d of similar to1 m
uM.